Novozymes A/S banner

Novozymes A/S
CSE:NSIS B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NSIS B
Watchlist
Price: 380.6 DKK -0.89% Market Closed
Market Cap: kr157.8B

P/B

11.8
Current
No historical data
Comparison unavailable

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
11.8
=
Market Cap
kr165.6B
/
Total Equity
kr14B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
11.8
=
Market Cap
kr165.6B
/
Total Equity
kr14B

Valuation Scenarios

Novozymes A/S is trading above its 3-year average

If P/B returns to its 3-Year Average (11.8), the stock would be worth kr380.6 (0% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-81%
Maximum Upside
No Upside Scenarios
Average Downside
20%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 11.8 kr380.6
0%
3-Year Average 11.8 kr380.6
0%
5-Year Average 11.8 kr380.6
0%
Industry Average 11.8 kr380.6
0%
Country Average 2.3 kr73.22
-81%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close
Market Cap P/B P/E
DK
Novozymes A/S
CSE:NSIS B
165.6B DKK 11.8 54.8
US
Sherwin-Williams Co
NYSE:SHW
80.3B USD 17.5 31.3
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
13.3T JPY 3.1 27.3
US
Ecolab Inc
NYSE:ECL
75.3B USD 7.7 36.3
JP
Yasuhara Chemical Co Ltd
TSE:4957
10.8T JPY 0.7 10.5
CN
Wanhua Chemical Group Co Ltd
SSE:600309
278.5B CNY 2.6 21.2
CH
Givaudan SA
SIX:GIVN
26B CHF 5.7 24.2
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.4T INR 12 61.2
US
PPG Industries Inc
NYSE:PPG
24.1B USD 3 15.3
US
Albemarle Corp
NYSE:ALB
22B USD 2.3 -32.5
CH
Sika AG
F:SIKA
19.9B EUR 2.7 17.5
P/E Multiple
Earnings Growth PEG
DK
Novozymes A/S
CSE:NSIS B
Average P/E: 29.9
54.8
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
31.3
14%
2.2
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
27.3
7%
3.9
US
Ecolab Inc
NYSE:ECL
36.3
14%
2.6
JP
Y
Yasuhara Chemical Co Ltd
TSE:4957
10.5
N/A N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.2
10%
2.1
CH
Givaudan SA
SIX:GIVN
24.2
6%
4
IN
Asian Paints Ltd
NSE:ASIANPAINT
61.2
15%
4.1
US
PPG Industries Inc
NYSE:PPG
15.3
10%
1.5
US
Albemarle Corp
NYSE:ALB
Negative Multiple: -32.5 N/A N/A
CH
Sika AG
F:SIKA
17.5
8%
2.2

Market Distribution

Higher than 92% of companies in Denmark
Percentile
92nd
Based on 438 companies
92nd percentile
11.2
Low
0.4 — 1.5
Typical Range
1.5 — 4.5
High
4.5 —
Distribution Statistics
Denmark
Min 0.4
30th Percentile 1.5
Median 2.3
70th Percentile 4.5
Max 44.6

Novozymes A/S
Glance View

Market Cap
157.8B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NSIS B Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett